Blexten (BLEKS-ten, bilastine) and Rupall (ROO-pal, rupatadine) are two new antihistamines on prescription.
"BLEXTEN (bilastine 20 mg oral tablet) is a second generation antihistamine drug for the treatment of Seasonal Allergic Rhinitis (SAR) and Chronic Spontaneous Urticaria (CSU). BLEXTEN exerts its effect as a selective histamine H1 receptor antagonist, and has an effectiveness comparable to cetirizine, fexofenadine and desloratadine."
"Rupatadine is a new second-generation antihistamine and platelet-activating factor (PAF) antagonist."
Blexten DIN is 2454130
Rupall DIN is 2456451
You can also read more on Canadian Pharmacist's Letter; February 2017; Vol: 33
News that has been personally selected by the Editorial team.